Hexima (ASX:HXL) Market Cap : A$1.84 Mil (As of May. 15, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Hexima Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hexima's share price for the quarter that ended in Dec. 2023 was A$0.018. Hexima's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 167.04 Mil. Therefore, Hexima's market cap for the quarter that ended in Dec. 2023 was A$3.01 Mil.

Hexima's quarterly market cap increased from Dec. 2022 (A$3.34 Mil) to Jun. 2023 (A$3.51 Mil) but then declined from Jun. 2023 (A$3.51 Mil) to Dec. 2023 (A$3.01 Mil).

Hexima's annual market cap declined from Jun. 2021 (A$22.25 Mil) to Jun. 2022 (A$5.01 Mil) and declined from Jun. 2022 (A$5.01 Mil) to Jun. 2023 (A$3.51 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hexima's Enterprise Value for Today is A$-0.08 Mil.

Hexima Market Cap Historical Data

The historical data trend for Hexima's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hexima Market Cap Chart

Hexima Annual Data

Trend

Jun08

Jun09

Jun10

Jun20

Jun21

Jun22

Jun23

Market Cap

Get a 7-Day Free Trial

22.25

5.01

3.51

Hexima Semi-Annual Data
	Dec06	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Market Cap	Get a 7-Day Free Trial										68.57	5.01	3.34	3.51	3.01

Competitive Comparison of Hexima's Market Cap

For the Biotechnology subindustry, Hexima's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hexima's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hexima's Market Cap distribution charts can be found below:

* The bar in red indicates where Hexima's Market Cap falls into.

Hexima Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Hexima's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as

Market Cap (A: Jun. 2023 )	=	Share Price (A: Jun. 2023 )	*	Shares Outstanding (EOP) (A: Jun. 2023 )
	=	A$0.021	*	167.04
	=	A$3.51

Hexima's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	A$0.018	*	167.04
	=	A$3.01

Hexima (ASX:HXL) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Hexima Market Cap Related Terms

Thank you for viewing the detailed overview of Hexima's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Hexima (ASX:HXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hexima Ltd (ASX:HXL) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

84-90 Hotham Street, Corporate One, Preston, VIC, AUS, 3072

Website

https://www.hexima.com.au

Hexima Ltd is a biotechnology company. The company is engaged in the research and development of plant-derived proteins and peptides for applications as human therapeutics.